Tecentriq Wins Approval
The U.S. Food and Drug Administration approved Roche’s new immunotherapy drug Tecentriq to be used in non-small cell lung cancer
Read More
Month: October 2016
Medicare shouldn’t pay more for drugs when others pay less
(By Brian C. Callaghan and Lindsey DeLott for ST A T) H illary Clinton and Donald Trump don’t see eye-to-eye
Read MoreOrgan Donation And The Opioid Epidemic: ‘An Unexpected Life-Saving Legacy’
(By Martha Bebinger, WBUR for Kaiser Health News) On the final day of June 2015, Colin LePage rode waves of
Read MoreBig Raises For Many Home Care Workers Won’t Necessarily Help Senior Citizens
(By Jane Gottlieb for Kaiser Health News) In recent months, health aides who care for elderly Americans at home appeared
Read MoreTreat pharma as a utility, and 10 other ways states can lower drug prices
(Ed Silverman for ST A T) A s prescription drug costs continue to squeeze state budgets, a group of state
Read MoreSettlement Reached to pay $28.1 Million
Omnicare, the nation’s largest nursing home pharmacy, reached an agreement with the U.S. Department of Justice to pay $28.1 million
Read MoreMedicare Part D: A First Look at Prescription Drug Plans in 2017
(By Jack Hoadley, Juliette Cubanski and Tricia Neuman for Kaiser Family Foundation published October 17, 2016) During the Medicare open
Read MoreHere are 3 big projects the White House cancer moonshot is pursuing
(By Dylan Scott for ST A T) L iquid biopsies. A “groundbreaking” Defense Department study. Partnerships with Lyft and Uber
Read MoreA Reboot For Wheelchair That Can Stand Up And Climb Stairs
(By Quil Lawrence for NPR) Thirteen years ago, just as the United States began what was to become its longest
Read More7 Insurers Alleged To Use Skimpy Drug Coverage To Discourage HIV Patients
(By Michelle Andrews for Kaiser Health News) The health law prohibits insurers from discriminating against people with serious illnesses, but
Read More